Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial

Payares-Herrera, Concepción; Martínez-Muñoz, María E.; Vallhonrat, Inés Lipperheide; de Molina, Rosa Malo; Torres, Manuel Pérez; Trisan, Andrea; de Diego, Isabel Salcedo; Alonso, Rosalía; Zafra, Rocío; Donaire, Trinidad; Sánchez, Rocío; Rubio, Juan José; Duarte Palomino, Rafael F.; Solá, Cristina Avendaño

doi:10.1186/s13063-020-04964-1

Trials

Article metrics
Last updated: Wed, 24 Apr 2024 5:31:03 Z

Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial

Access & Citations

3983

Article Accesses
10

Web of Science
12

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1745-6215

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com